Tag: setipiprant

Actelion to end setipiprant clinical development in asthma, allergic rhinitisRTT NewsPK: News ) on Monday said two recently concluded studies with the first orally-active CRTH2 antagonist, setipiprant, in asthma and seasonal allergic rhinitis did not confirm efficacy findings made in earlier studies. Accordingly, the company is …Actelion provides update on CRTH2 programReutersall 11 news articles »…